European Leukemia Trial Registry
Trial: Isavuconazole WSA-CS-004

More Details
Title Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
Scientific Title A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.
Short Title Isavuconazole WSA-CS-004
Trialgroup AGIHO
Disease Miscellaneous(Miscellaneous) Supportive Care
Age >= 18 years
Status Closed
Start of Recruitment 12.11.2007
Leader Cornely, Prof. Dr., Oliver A.
Centre of Trial Universitätsklinikum der Universität zu Köln
Shortprotocol Shortprotocol
created 09.12.2008 5 Roswitha Kotthoff
changed 20.03.2015 Hanna Ebert
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | |